SHENZHEN CHANGHONG TECHNOLOGY CO., LTD. Shenzhen Changhong Technology Co., Ltd. Stock
Equities
300151
CNE100000Y35
Industrial Machinery & Equipment
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.76 CNY | +0.54% |
|
+7.42% | -19.70% |
| Sales 2023 | 931M 129M | Sales 2024 * | 1.35B 187M | Capitalization | 7.86B 1.08B |
|---|---|---|---|---|---|
| Net income 2023 | 31M 4.28M | Net income 2024 * | 172M 23.74M | EV / Sales 2023 | 10.5 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 5.81 x |
| P/E ratio 2023 |
306
x | P/E ratio 2024 * |
46.1
x | Employees | 2,595 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 27.8% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.54% | ||
| 1 week | +7.42% | ||
| Current month | -2.19% | ||
| 1 month | +1.03% | ||
| 3 months | -0.94% | ||
| 6 months | -15.66% | ||
| Current year | -19.70% |
1 week
13.46
15.08
1 month
13.4616.56
Current year
10.2418.49
1 year
10.2419.85
3 years
10.2444.20
5 years
5.8044.20
10 years
3.7444.20
| Managers | Title | Age | Since |
|---|---|---|---|
Huan Chang Li
CEO | Chief Executive Officer | 55 | 01-04-10 |
Guo Quan Zhou
DFI | Director of Finance/CFO | 65 | 06-04-30 |
Yan-Ping Xu
BRD | Director/Board Member | 57 | 01-04-10 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Huan Chang Li
CEO | Chief Executive Officer | 55 | 01-04-10 |
Yan-Ping Xu
BRD | Director/Board Member | 57 | 01-04-10 |
A Rong Zhao
BRD | Director/Board Member | 63 | 03-06-30 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 34 M€ | +2.14% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 14.76 | +0.54% | 4,312,366 |
| 24-04-25 | 14.68 | -0.81% | 3,308,500 |
| 24-04-24 | 14.8 | +0.41% | 3,521,149 |
| 24-04-23 | 14.74 | +2.65% | 4,908,175 |
| 24-04-22 | 14.36 | +4.51% | 5,712,092 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
SHENZHEN CHANGHONG TECHNOLOGY CO., LTD. is a China-based company principally engaged in the research, development, design, manufacture and sales of medical instruments and precision plastic moulds. The Company's main products include medical consumables and reagents, moulds and matching injection products and others. The Company distributes its products in domestic market and to overseas markets.
Calendar
2024-08-27
- Q2 2024 Earnings Release (Projected)
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14.76
CNY
Average target price
23
CNY
Spread / Average Target
+55.83%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -19.70% | 1.08B | |
| +3.58% | 1.17B | |
| -12.67% | 841M | |
| -36.24% | 700M | |
| +50.64% | 645M | |
| -14.98% | 559M | |
| -2.48% | 443M | |
| -4.81% | 416M | |
| -26.69% | 410M | |
| -4.70% | 393M |
- Stock Market
- Equities
- 300151 Stock
